Summary

CBS C699T is a synonymous variant linked to enhanced transsulfuration — the alternative homocysteine clearance route. The T allele appears mildly protective: better folate response, lower post-load homocysteine, and reduced CAD risk. It partially compensates for MTHFR impairment, making it the methylation pathway's safety valve.

Genotype spectrum

CC (Wild type)

Normal homocysteine partitioning between remethylation and transsulfuration. Standard methylation balance.

CT (Heterozygous)

You likely clear post-methionine-load homocysteine slightly faster than average. Your transsulfuration pathway is a modest safety valve for methylation pathway bottlenecks.

TT (Homozygous)

Your transsulfuration is genuinely upregulated. You respond significantly better to folate supplementation (Kruger 2000: 3x better homocysteine response).

Practical takeaway

For TT Carriers (Moderate Attention)
• Pyridoxal-5'-phosphate (P5P): 25-50 mg/day. Your CBS likely has enhanced expression — give it adequate cofactor to function optimally.
• Methylfolate: Standard dose per MTHFR status. You respond ~3x better to folate supplementation than CC carriers (Kruger 2000).
• Test: Homocysteine (fasting + ideally post-methionine load). Your post-load Hcy should be lower than average — if it's elevated, suspect B6 deficiency or concurrent MTR/MTRR impairment overriding the CBS advantage.
• If stacked with MTHFR TT: Your CBS is partially compensating for impaired remethylation. This is genuinely protective for homocysteine, but monitor SAM/methionine status (functional indicators: mood, energy, cognitive function). The combination means more homocysteine exits via transsulfuration instead of being recycled to methionine.
For CT Carriers (Low Priority Alone)
• Standard B6 adequacy. P5P is a reasonable form choice.
• Becomes relevant when stacked with MTHFR or MTR variants as a compensatory modifier.
For CC Carriers (No Action)
• Normal CBS expression. Standard dietary guidance.
• If carrying MTHFR TT, your transsulfuration compensation is not enhanced — homocysteine management relies more heavily on the remethylation route. B12 and folate become higher priority.

Evidence detail

What This Gene Does

CBS (cystathionine beta-synthase) is the first enzyme in the transsulfuration pathway. It takes homocysteine and serine and converts them to cystathionine — the first step toward making cysteine, glutathione, and hydrogen sulfide (H2S). This is the ALTERNATIVE route for clearing homocysteine, distinct from the remethylation route (MTR → methionine).

CBS requires pyridoxal-5'-phosphate (active B6) as its cofactor and is allosterically activated by SAM — when SAM levels are high (indicating adequate methylation), SAM switches CBS on, diverting homocysteine toward glutathione production instead of recycling it to methionine. This is an elegant feedback loop: when the cell has enough methyl groups, it sends excess homocysteine toward antioxidant defence.

The C699T variant (rs234706) is a synonymous change — Tyr233Tyr — that does NOT alter the CBS protein itself. Its effects are thought to come from linkage disequilibrium with nearby regulatory elements that increase CBS transcription. The T allele is associated with enhanced transsulfuration capacity.

Mechanism

CBS performs the transsulfuration pathway's entry reaction:

Homocysteine + Serine → Cystathionine (requires PLP/B6, activated by SAM)

The C699T variant is synonymous (Tyr233Tyr) — it doesn't change the CBS protein. Here's what's actually happening:

1. The T allele is in linkage disequilibrium with regulatory elements that appear to increase CBS transcription. This means T allele carriers may produce more CBS enzyme, not a different enzyme.

2. Enhanced transsulfuration capacity means: More homocysteine gets diverted through the CBS route → cystathionine → cysteine → glutathione. This is the "safety valve" for homocysteine clearance when the remethylation route (MTR) is bottlenecked.

3. The SAM feedback loop: When SAM is abundant, it activates CBS ~5-fold. In T allele carriers with already-higher CBS expression, this activation is amplified. Result: faster homocysteine clearance through transsulfuration when methylation is proceeding well.

4. The MTHFR compensation: If MTHFR is impaired (C677T TT), less methylfolate is available for remethylation via MTR. CBS T allele partially compensates by providing an alternative homocysteine exit route. De Stefano 1998 confirmed this directly: the CBS insertion eliminated MTHFR's homocysteine-raising effect.

5. The trade-off: Enhanced transsulfuration clears homocysteine but may deplete the methionine/SAM pool faster. Homocysteine diverted through CBS is NOT recycled to methionine — it's permanently committed to glutathione production. This matters when stacked with MTHFR/MTR impairment: the remethylation route is weak AND the transsulfuration route is pulling homocysteine away from methionine recycling.

Think of it as: CBS is the overflow drain in the methylation bathtub. The T allele makes the drain bigger. When the main recycling pump (MTR/MTHFR) is working well, a bigger drain means less flooding (lower homocysteine). When the pump is broken, a bigger drain means the tub empties faster in the wrong direction (methionine depletion).

CBS C699T

Summary

Genotype spectrum

Practical takeaway

Evidence detail

Sources (10)